The research peptide market contains significant counterfeiting and mislabeling
Interruptions in coverage, changes in insurance policies, or fluctuations in medication availability can disrupt treatment continuity
Helps reduce oil without drying you out 5
Rather than a reason to stop, it is often a signal that the antioxidant is doing its job
Later in 2022, the FDA granted tirzepetide fast track designation for overweight and obesity in adults.6 To date, tirzepetide hasnt been FDA approved for weight loss (see table Current FDA-Approved Mono and Dual Agonists for details about weight management medications)
These are effective, game-changing medications, but they need to be used appropriately. Jaime Almandoz Watch a recording of the full discussion about GLP-1s below